Source: International Congress 2014 – ILDs 5
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Chandrashekariah, D. Rosha (New Delhi, India). Sarcoidosis in India: Investigation into vitamin D and calcium metabolism. Eur Respir J 2014; 44: Suppl. 58, 3777

Member's Comments

No comment yet.

Related content which might interest you: Atypical variants of clinical course of sarcoidosis Source: International Congress 2014 – ILDs 6 Year: 2014 Extrapulmonary involvement in sarcoidosis patients Source: International Congress 2014 – ILDs 4 Year: 2014 Cognitive failure in sarcoidosis Source: International Congress 2014 – Sarcoidosis Year: 2014 Sarcoidosis related to interferon and ribavirin treatment of hepatitis C – Analysis of four cases Source: International Congress 2014 – Sarcoidosis Year: 2014 Serum levels of sestrin 2 in patients with sarcoidosis Source: International Congress 2014 – ILDs 6 Year: 2014 Diagnosis of cardiac sarcoidosis: A crossectional study in 327 consecutive patients Source: International Congress 2014 – Sarcoidosis Year: 2014 How many patients require corticosteroid treatment in sarcoidosis? – Preliminary study Source: International Congress 2014 – Sarcoidosis Year: 2014 Predictors of cardiovascular events in newly diagnosed patients with sarcoidosis Source: International Congress 2014 – Sarcoidosis Year: 2014 Is pulmonary sarcoidosis more severe in children? A multicentric retrospective study Source: International Congress 2014 – Sarcoidosis Year: 2014 Heat shock proteins as 'danger signals' in sarcoidosis Source: International Congress 2014 – ILDs 6 Year: 2014 Neuroendocrine cell hyperplasia (NEHI) and NEHI Syndrome: Lung biopsy necessary? Source: International Congress 2014 – ILDs 4 Year: 2014 Benefit of steroid-free treatment compared to standard therapy (ST) in pulmonary sarcoidosis Source: International Congress 2014 – ILDs 5 Year: 2014 Assessment of Treatment Response in Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment Year: 2019 European pulmonary alveolar proteinosis network (EuPAPNet): Results from biomarkers´ investigation Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis Year: 2014 Comparative phenotype and BTNL2 polymorphism in familial and sporadic sarcoidosis in the French SARCFAM cohort Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis Year: 2014 Clinical characteristics of a Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH)  Cohort Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key Year: 2020 Mutation alone does not predict the clinical course of surfactant protein C deficiency in children Source: International Congress 2014 – ILDs: pathogenesis and clinical features Year: 2014 Reduction in disease progression with nintedanib in the INPULSIS™ trials Source: International Congress 2014 – Clinical trials in IPF Year: 2014 Impact of smoking habit on lung function in a large cohort sarcoidosis patients. Source: International Congress 2014 – Sarcoidosis Year: 2014 Comorbidities associated with sarcoidosis – Results from long-term observational study Source: International Congress 2014 – Sarcoidosis Year: 2014